Pfizer Inc.PFENYSE
Loading
Interest Expense Over TimeContracting
Percentile Rank93
3Y CAGR+29.2%
5Y CAGR+13.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+29.2%/yr
vs -1.5%/yr prior
5Y CAGR
+13.0%/yr
Recent acceleration
Acceleration
+30.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.67B | -13.6% |
| 2024 | $3.09B | +39.9% |
| 2023 | $2.21B | +78.4% |
| 2022 | $1.24B | -4.1% |
| 2021 | $1.29B | -10.9% |
| 2020 | $1.45B | -7.9% |
| 2019 | $1.57B | +19.5% |
| 2018 | $1.32B | +3.6% |
| 2017 | $1.27B | +7.1% |
| 2016 | $1.19B | - |